Nura A. Mohamed

Evidence for the Involvement of Type I Interferon in Pulmonary Arterial Hypertension

Peter M. George, Eduardo Oliver, Peter Dorfmüller et al. · Circulation Research · 2013 · 155 citations · Full text

Medicine, Cardiology, Immunology +10

Role of prostacyclin in pulmonary hypertension

Jane A. Mitchell, Blerina Ahmetaj‐Shala, Nicholas S. Kirkby et al. · Global Cardiology Science and Practice · 2014 · 81 citations · Full text

Medicine, Cardiology, Pharmacology +13

Chemical and biological assessment of metal organic frameworks (MOFs) in pulmonary cells and in an acute in vivo model: relevance to pulmonary arterial hypertension therapy

Nura A. Mohamed, Robert P. Davies, Paul D. Lickiss et al. · Pulmonary Circulation · 2017 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

P2Y₁₂receptor blockade synergizes strongly with nitric oxide and prostacyclin to inhibit platelet activation

Melissa V. Chan, Rebecca Knowles, Martina H. Lundberg et al. · British Journal of Clinical Pharmacology · 2015 · 34 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +16

Studies on metal–organic framework (MOF) nanomedicine preparations of sildenafil for the future treatment of pulmonary arterial hypertension

Nura A. Mohamed, Haissam Abou-Saleh, Y Kameno et al. · Scientific Reports · 2021 · 33 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17